Sukhjot Kaur
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sukhjot Kaur has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Alka Dogra
From the Department of Dermatology and Venereology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India
2 shared publicationsAminder Singh
Department of Pathology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India
2 shared publicationsJaskaran Batra
Professor Pathology, DMCH, Ludhiana, Punjab, India
2 shared publications- Jaspriya Sandhu
Department of Dermatology, Venereology and Leprology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India
2 shared publications Kittu Malhi
Department of Dermatology, Venereology and Leprology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India
2 shared publicationsAditi Bansal
Department of Dermatology, Venereology and Leprology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India
1 shared publication
Latest Publications
- 4 June 2026
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. -1 (aop)
Rural Dermatology in the Subtropics: A Cross-Sectional Study of Patterns of Dermatoses, Follow-Up Visits, and Treatment Compliance at a Rural Health Center in North India
: Dermatological conditions pose a significant global public health burden, with a paucity of data from rural-based dermatology services providing longitudinal care. The present prospective study was conducted between November 1, 2022 and April 30, 2023, to study the pattern of dermatoses, treatment adherence, and follow-up among patients seen by the dermatology service at a rural health center in north India. After appropriate ethical clearance and informed consent, all patients were screened for dermatological diseases, and clinicodemographic details were recorded. On subsequent visits, compliance with follow-up and treatment adherence were assessed through direct patient interviews and review of medical records. A total of 538 study participants (mean age = 36.2 ± 18.0 years) were included; females outnumbered males (male-to-female ratio = 0.79). Dermatophytic infections (24%), eczema (16.6%), scabies (13.2%), acne (10.6%), and pigmentary diseases (8.9%) were observed. Treatment adherence was observed in 17.8% of patients; 16.7% of patients followed up at the prescribed time. The majority of patients with dermatophytic infections (75.4%) had at least one follow-up visit ( P = 0.003). Noninfectious diseases were more common among older age groups ( P = 0.034), whereas scabies was more common among the young ( P = 0.001). Dermatophytic infections were the most common dermatoses seen among the rural population, with poor follow-up and low treatment adherence. Noncompliance was due to a lack of a caregiver or transportation and financial reasons, among others. The present study highlights the urban–rural gap in dermatology care, demonstrating a diverse spectrum of dermatoses, low treatment adherence, and poor follow-up in a rural population. The present study raises the need for increased awareness, improved community dermatology services, and strengthened rural outreach and emphasizes the potential benefits of enhanced dermatological care for underserved populations.
- 4 June 2026
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. -1 (aop)
Rural Dermatology in the Subtropics: A Cross-Sectional Study of Patterns of Dermatoses, Follow-Up Visits, and Treatment Compliance at a Rural Health Center in North India
: Dermatological conditions pose a significant global public health burden, with a paucity of data from rural-based dermatology services providing longitudinal care. The present prospective study was conducted between November 1, 2022 and April 30, 2023, to study the pattern of dermatoses, treatment adherence, and follow-up among patients seen by the dermatology service at a rural health center in north India. After appropriate ethical clearance and informed consent, all patients were screened for dermatological diseases, and clinicodemographic details were recorded. On subsequent visits, compliance with follow-up and treatment adherence were assessed through direct patient interviews and review of medical records. A total of 538 study participants (mean age = 36.2 ± 18.0 years) were included; females outnumbered males (male-to-female ratio = 0.79). Dermatophytic infections (24%), eczema (16.6%), scabies (13.2%), acne (10.6%), and pigmentary diseases (8.9%) were observed. Treatment adherence was observed in 17.8% of patients; 16.7% of patients followed up at the prescribed time. The majority of patients with dermatophytic infections (75.4%) had at least one follow-up visit ( P = 0.003). Noninfectious diseases were more common among older age groups ( P = 0.034), whereas scabies was more common among the young ( P = 0.001). Dermatophytic infections were the most common dermatoses seen among the rural population, with poor follow-up and low treatment adherence. Noncompliance was due to a lack of a caregiver or transportation and financial reasons, among others. The present study highlights the urban–rural gap in dermatology care, demonstrating a diverse spectrum of dermatoses, low treatment adherence, and poor follow-up in a rural population. The present study raises the need for increased awareness, improved community dermatology services, and strengthened rural outreach and emphasizes the potential benefits of enhanced dermatological care for underserved populations.
- Open Access
- 24 October 2025
- Published by Wolters Kluwer Health in Indian Dermatology Online Journal
- Vol. 16 (6) , 991-994
Unusual Presentation of Bullous Pemphigoid as Erythroderma in an Elderly Male
- 24 October 2025
- Published by Wolters Kluwer Health in Indian Dermatology Online Journal
- Vol. 16 (6) , 991-994
Open AccessUnusual Presentation of Bullous Pemphigoid as Erythroderma in an Elderly Male
- Open Access
- 1 January 2025
- Published by Wolters Kluwer Health in Indian Journal of Paediatric Dermatology
- Vol. 26 (1) , 44-46
Bowing of the Legs and Alopecia Universalis in a Young Boy
We present a compelling case of Vitamin D-dependent rickets type IIA (VDDR2a) in a young boy, emphasizing the challenges in diagnosing genetic forms of rickets, particularly in developing nations like India where nutritional rickets are prevalent. VDDR2a, stemming from VD receptor gene mutations, showcases a unique instance of tissue resistance to VD. The case illustrates characteristic clinical features such as infantile-onset alopecia, skeletal deformities, and dental enamel defects. The diagnosis, facilitated by genetic sequencing, elucidates a homozygous splice site variation in the VDR gene, underlining the significance of early identification for effective management. The presence of alopecia highlights the severity and complexity of VDDR2a cases. Biochemical and radiographic findings further corroborate the diagnosis. The discussion delves into the nuanced clinical spectrum of VDDR2a, emphasizing the role of specific VDR mutations in eliciting diverse manifestations. Our case underscores the necessity for a meticulous diagnostic approach, distinguishing VDDR2a from other congenital alopecia disorders. Treatment strategies, though challenging, aim to mitigate complications through timely intervention. This study contributes to the medical literature by shedding light on a rare genetic disorder, accentuating the importance of early diagnosis and tailored management in optimizing clinical outcomes for affected individuals, especially in resource-constrained settings.
- 1 January 2025
- Published by Wolters Kluwer Health in Indian Journal of Paediatric Dermatology
- Vol. 26 (1) , 44-46
Open AccessBowing of the Legs and Alopecia Universalis in a Young Boy
We present a compelling case of Vitamin D-dependent rickets type IIA (VDDR2a) in a young boy, emphasizing the challenges in diagnosing genetic forms of rickets, particularly in developing nations like India where nutritional rickets are prevalent. VDDR2a, stemming from VD receptor gene mutations, showcases a unique instance of tissue resistance to VD. The case illustrates characteristic clinical features such as infantile-onset alopecia, skeletal deformities, and dental enamel defects. The diagnosis, facilitated by genetic sequencing, elucidates a homozygous splice site variation in the VDR gene, underlining the significance of early identification for effective management. The presence of alopecia highlights the severity and complexity of VDDR2a cases. Biochemical and radiographic findings further corroborate the diagnosis. The discussion delves into the nuanced clinical spectrum of VDDR2a, emphasizing the role of specific VDR mutations in eliciting diverse manifestations. Our case underscores the necessity for a meticulous diagnostic approach, distinguishing VDDR2a from other congenital alopecia disorders. Treatment strategies, though challenging, aim to mitigate complications through timely intervention. This study contributes to the medical literature by shedding light on a rare genetic disorder, accentuating the importance of early diagnosis and tailored management in optimizing clinical outcomes for affected individuals, especially in resource-constrained settings.
- Open Access
- 8 August 2024
- Published by Scientific Scholar in Indian Journal of Dermatology, Venereology and Leprology
- Vol. 92, 228-231
A life-threatening consequence of erythema nodosum leprosum
- 8 August 2024
- Published by Scientific Scholar in Indian Journal of Dermatology, Venereology and Leprology
- Vol. 92, 228-231
Open AccessA life-threatening consequence of erythema nodosum leprosum
- Open Access
- 6 September 2022
- Published by Scientific Scholar in Journal of Clinical Imaging Science
- Vol. 2, 79
Clinicoimmunologic pattern, therapeutic response, and outcomes in connective tissue disease patients receiving steroid pulse therapy
Objectives: The aim of the study was to examine the clinicoimmunologic pattern, therapeutic response, and long-term outcomes in connective tissue disease (CTD) patients who received steroid pulse therapy. Material and Methods: Patients diagnosed with CTD (including diffuse cutaneous systemic sclerosis [dcSS], systemic lupus erythematosus [SLE], subacute cutaneous lupus erythematosus [SCLE], mixed CTD [MCTD], or overlap syndrome) who received steroid pulse therapy (period July 2017–June 2019) were identified in the hospital database and their relevant data were retrieved. Patients were followed up in June 2020 and response to treatment was evaluated by a self-devised patient-reported assessment scale. Results: Among the CTDs (n = 22; M: F = 1:6.3. Mean age = 39.95 ± 11.2 years), dcSS (45.5%) was the most common CTD seen followed by SLE (31.8%), MCTD (9.1%), SCLE (9.1%), and overlap syndrome (4.5%). CTD patients most commonly presented with joint pains (77.2%) or Raynaud’s phenomenon (77.2%). Antinuclear antibody (ANA) was positive in all patients. Fourteen patients received methylprednisolone; seven dexamethasone pulse, and one received dexamethasone-cyclophosphamide pulse. Only 10 patients could be followed up (mean duration of follow-up = 12.8 ± 6.4 months); two had complete remission, that is, clear; two had considerable benefit. Two did not tolerate pulse therapy and two died. Conclusion: Pulsed steroids can be a well-tolerated therapeutic modality with some benefit in CTD patients presenting to a dermatologist.
- 6 September 2022
- Published by Scientific Scholar in Journal of Clinical Imaging Science
- Vol. 2, 79
Open AccessClinicoimmunologic pattern, therapeutic response, and outcomes in connective tissue disease patients receiving steroid pulse therapy
Objectives: The aim of the study was to examine the clinicoimmunologic pattern, therapeutic response, and long-term outcomes in connective tissue disease (CTD) patients who received steroid pulse therapy. Material and Methods: Patients diagnosed with CTD (including diffuse cutaneous systemic sclerosis [dcSS], systemic lupus erythematosus [SLE], subacute cutaneous lupus erythematosus [SCLE], mixed CTD [MCTD], or overlap syndrome) who received steroid pulse therapy (period July 2017–June 2019) were identified in the hospital database and their relevant data were retrieved. Patients were followed up in June 2020 and response to treatment was evaluated by a self-devised patient-reported assessment scale. Results: Among the CTDs (n = 22; M: F = 1:6.3. Mean age = 39.95 ± 11.2 years), dcSS (45.5%) was the most common CTD seen followed by SLE (31.8%), MCTD (9.1%), SCLE (9.1%), and overlap syndrome (4.5%). CTD patients most commonly presented with joint pains (77.2%) or Raynaud’s phenomenon (77.2%). Antinuclear antibody (ANA) was positive in all patients. Fourteen patients received methylprednisolone; seven dexamethasone pulse, and one received dexamethasone-cyclophosphamide pulse. Only 10 patients could be followed up (mean duration of follow-up = 12.8 ± 6.4 months); two had complete remission, that is, clear; two had considerable benefit. Two did not tolerate pulse therapy and two died. Conclusion: Pulsed steroids can be a well-tolerated therapeutic modality with some benefit in CTD patients presenting to a dermatologist.
- Open Access
- 1 March 2022
- Published by Medknow in Indian Dermatology Online Journal
- Vol. 13 (2) , 244-247
Pyoderma Gangrenosum with Splenic Abscess- A Rare Association
Pyoderma gangrenosum is a rare, chronic neutrophilic dermatosis of unknown etiology. The classical clinical feature of pyoderma gangrenosum is a pustule or plaque that rapidly progresses to a painful, necrotic ulcer with undermined violaceous margins. Pyoderma gangrenosum may be associated with underlying inflammatory bowel diseases, hematological malignancies, or rheumatologic disorders in 50–70% of the cases. The visceral involvement by pyoderma gangrenosum is rare. Sterile neutrophilic infiltrates in organs other than the skin are uncommon systemic manifestations of neutrophilic dermatoses, but have occasionally been reported. We report a case of a 38-year-old female with pyoderma gangrenosum and visceral involvement manifesting as splenic abscess.
- 1 March 2022
- Published by Medknow in Indian Dermatology Online Journal
- Vol. 13 (2) , 244-247
Open AccessPyoderma Gangrenosum with Splenic Abscess- A Rare Association
Pyoderma gangrenosum is a rare, chronic neutrophilic dermatosis of unknown etiology. The classical clinical feature of pyoderma gangrenosum is a pustule or plaque that rapidly progresses to a painful, necrotic ulcer with undermined violaceous margins. Pyoderma gangrenosum may be associated with underlying inflammatory bowel diseases, hematological malignancies, or rheumatologic disorders in 50–70% of the cases. The visceral involvement by pyoderma gangrenosum is rare. Sterile neutrophilic infiltrates in organs other than the skin are uncommon systemic manifestations of neutrophilic dermatoses, but have occasionally been reported. We report a case of a 38-year-old female with pyoderma gangrenosum and visceral involvement manifesting as splenic abscess.
- Open Access
- 1 January 2022
- Published by Medknow in Indian Dermatology Online Journal
- Vol. 13 (1) , 128-130
Enfortumab vedotin-induced toxic epidermal necrolysis: A rare fatal adverse reaction
Indian Dermatol Online J, Official publication of IADVL
- 1 January 2022
- Published by Medknow in Indian Dermatology Online Journal
- Vol. 13 (1) , 128-130
Open AccessEnfortumab vedotin-induced toxic epidermal necrolysis: A rare fatal adverse reaction
Indian Dermatol Online J, Official publication of IADVL
- Open Access
- 1 July 2021
- Published by Medknow in Journal of Postgraduate Medicine
- Vol. 67 (3) , 158-163
DRESS syndrome induced by imatinib
Drug rash with eosinophilia and systemic symptoms (DRESS syndrome) is a severe, potentially life-threatening drug-induced hypersensitivity reaction characterized by cutaneous eruptions, fever, diffuse lymphadenopathy, along with eosinophilia and elevated liver enzymes. The severity and potential organ damage associated with DRESS mandates withdrawing the offending drug and provide a suitable replacement. We report a 55-year-old man who developed prolonged fever, generalized maculopapular rash and facial edema after 3 weeks of starting imatinib for chronic myeloid leukemia (CML). A diagnosis of DRESS was confirmed by eosinophilia and skin biopsy findings, along with a consistent RegiSCAR score. Imatinib was stopped and he was initiated on low-dose steroids, which led to complete resolution of rash and eosinophilia. A rechallenge with imatinib was positive, and he was switched to dasatinib for further therapy, following which he attained an optimal molecular response. DRESS following imatinib has only been reported in eight patients so far. In this report we summarize the current evidence for managing DRESS and its impact on the treatment of CML.
- 1 July 2021
- Published by Medknow in Journal of Postgraduate Medicine
- Vol. 67 (3) , 158-163
Open AccessDRESS syndrome induced by imatinib
Drug rash with eosinophilia and systemic symptoms (DRESS syndrome) is a severe, potentially life-threatening drug-induced hypersensitivity reaction characterized by cutaneous eruptions, fever, diffuse lymphadenopathy, along with eosinophilia and elevated liver enzymes. The severity and potential organ damage associated with DRESS mandates withdrawing the offending drug and provide a suitable replacement. We report a 55-year-old man who developed prolonged fever, generalized maculopapular rash and facial edema after 3 weeks of starting imatinib for chronic myeloid leukemia (CML). A diagnosis of DRESS was confirmed by eosinophilia and skin biopsy findings, along with a consistent RegiSCAR score. Imatinib was stopped and he was initiated on low-dose steroids, which led to complete resolution of rash and eosinophilia. A rechallenge with imatinib was positive, and he was switched to dasatinib for further therapy, following which he attained an optimal molecular response. DRESS following imatinib has only been reported in eight patients so far. In this report we summarize the current evidence for managing DRESS and its impact on the treatment of CML.
- Open Access
- 1 January 2021
- Published by Medknow in Indian Dermatology Online Journal
- Vol. 12 (1) , 66-71
A Clinicopathological Study of Skin Tumors from a Tertiary Care Centre in North India
Background: There is a huge spectrum of skin tumors which can be confused clinically with malignancies, particularly when they are pigmented or inflamed, and histopathological examination of a biopsy specimen is required to establish a definitive diagnosis and to facilitate appropriate intervention and follow up. Aim: To evaluate all skin tumors and categorize them according to their origin. Methods: The present study was conducted over a period of 4 years (July 1, 2013 to June 31, 2017) comprising of 1.5 years prospective and 2.5 years retrospective analysis in the departments of Dermatology and Pathology, at a tertiary hospital in North India. All specimens of skin tumors were analyzed grossly and microscopically. Immunohistochemistry was done wherever possible. Results: A total of 232 skin tumors were seen; of which 123 cases were benign (53.0%) and 109 cases were malignant (47.0%). The mean age of patients with benign and malignant skin tumors was 40.3 ± 19.9 and 60.8 ± 14.8 years, respectively. The most common site was face (n = 106; 45.7%) followed by limbs (n = 44; 19.0%). The male:female ratio of benign and malignant tumors was 1.01:1 and 1.31:1, respectively. Among the benign tumors, keratinocytic tumors were the commonest (n = 57; 46.3%) followed by the melanocytic tumors (n = 37; 30.1%) and appendageal tumors (n = 29; 23.6%). The most common malignant skin tumors were the keratinocytic tumors (n = 87; 79.8%) followed by 12 cases (11%) of hematolymphoid tumors and five cases (4.6%) each of melanocytic and appendageal tumors. Limitations: The lack of clinical and dermatoscopic correlation and inclusion of retrospective data are the limitations of this study. Conclusions: Skin tumors affect people of all ages. The benign tumors are seen in the younger age group as compared to malignant tumors. Face is the most common site and keratinocytic tumors are the most common skin tumors in both benign and malignant categories.
- 1 January 2021
- Published by Medknow in Indian Dermatology Online Journal
- Vol. 12 (1) , 66-71
Open AccessA Clinicopathological Study of Skin Tumors from a Tertiary Care Centre in North India
Background: There is a huge spectrum of skin tumors which can be confused clinically with malignancies, particularly when they are pigmented or inflamed, and histopathological examination of a biopsy specimen is required to establish a definitive diagnosis and to facilitate appropriate intervention and follow up. Aim: To evaluate all skin tumors and categorize them according to their origin. Methods: The present study was conducted over a period of 4 years (July 1, 2013 to June 31, 2017) comprising of 1.5 years prospective and 2.5 years retrospective analysis in the departments of Dermatology and Pathology, at a tertiary hospital in North India. All specimens of skin tumors were analyzed grossly and microscopically. Immunohistochemistry was done wherever possible. Results: A total of 232 skin tumors were seen; of which 123 cases were benign (53.0%) and 109 cases were malignant (47.0%). The mean age of patients with benign and malignant skin tumors was 40.3 ± 19.9 and 60.8 ± 14.8 years, respectively. The most common site was face (n = 106; 45.7%) followed by limbs (n = 44; 19.0%). The male:female ratio of benign and malignant tumors was 1.01:1 and 1.31:1, respectively. Among the benign tumors, keratinocytic tumors were the commonest (n = 57; 46.3%) followed by the melanocytic tumors (n = 37; 30.1%) and appendageal tumors (n = 29; 23.6%). The most common malignant skin tumors were the keratinocytic tumors (n = 87; 79.8%) followed by 12 cases (11%) of hematolymphoid tumors and five cases (4.6%) each of melanocytic and appendageal tumors. Limitations: The lack of clinical and dermatoscopic correlation and inclusion of retrospective data are the limitations of this study. Conclusions: Skin tumors affect people of all ages. The benign tumors are seen in the younger age group as compared to malignant tumors. Face is the most common site and keratinocytic tumors are the most common skin tumors in both benign and malignant categories.
- 11 October 2018
- Published by Wiley in Pediatric Dermatology
- Vol. 35 (6) , 796-799
Dermatologic findings of vitamin B12 deficiency in infants
Background/Objectives: Vitamin B12 deficiency in infants is uncommonly reported from developed countries and generally lacks dermatologic manifestations. On the contrary, infantile vitamin B12 deficiency is common in India and cutaneous manifestations are a constant feature, although often overshadowed by neurologic and hematological manifestations. The aim of this study was to describe the skin changes of vitamin B12 deficiency in infants.Materials and Methods: A retrospective chart review of vitamin B12 deficient infants for clinical and laboratory parameters was performed and data analyzed.Results: Forty‐three infants, 30 boys and 13 girls, aged 4 to 27 months, with vitamin B12 deficiency were identified. Skin hyperpigmentation was present in 41 infants; it was localized to the dorsa of hands and feet in 26. Fifteen infants had generalized hyperpigmentation; 10 had a reticulate pattern, and 5 had a homogeneous pattern. Brown and sparse scalp hair were present in all. Glossitis was seen in 5 infants and cheilitis in 3. Of the 32 infants who underwent laboratory investigations, 28 had anemia and 21 macrocytosis. Serum vitamin B12 was measured in 30 infants; it was low in 19. Of the 11 with normal serum vitamin B12, 9 had received vitamin B12 before referral but had macrocytosis and low maternal serum vitamin B12. The infants were treated with vitamin B12. Skin pigmentation and mucosal changes resolved completely by 3‐4 weeks, but hair changes were slower to reverse.Conclusion: Cutaneous findings are a common feature of vitamin B12 deficiency in Indian infants and resolve with treatment.
- 11 October 2018
- Published by Wiley in Pediatric Dermatology
- Vol. 35 (6) , 796-799
Dermatologic findings of vitamin B12 deficiency in infants
Background/Objectives: Vitamin B12 deficiency in infants is uncommonly reported from developed countries and generally lacks dermatologic manifestations. On the contrary, infantile vitamin B12 deficiency is common in India and cutaneous manifestations are a constant feature, although often overshadowed by neurologic and hematological manifestations. The aim of this study was to describe the skin changes of vitamin B12 deficiency in infants.Materials and Methods: A retrospective chart review of vitamin B12 deficient infants for clinical and laboratory parameters was performed and data analyzed.Results: Forty‐three infants, 30 boys and 13 girls, aged 4 to 27 months, with vitamin B12 deficiency were identified. Skin hyperpigmentation was present in 41 infants; it was localized to the dorsa of hands and feet in 26. Fifteen infants had generalized hyperpigmentation; 10 had a reticulate pattern, and 5 had a homogeneous pattern. Brown and sparse scalp hair were present in all. Glossitis was seen in 5 infants and cheilitis in 3. Of the 32 infants who underwent laboratory investigations, 28 had anemia and 21 macrocytosis. Serum vitamin B12 was measured in 30 infants; it was low in 19. Of the 11 with normal serum vitamin B12, 9 had received vitamin B12 before referral but had macrocytosis and low maternal serum vitamin B12. The infants were treated with vitamin B12. Skin pigmentation and mucosal changes resolved completely by 3‐4 weeks, but hair changes were slower to reverse.Conclusion: Cutaneous findings are a common feature of vitamin B12 deficiency in Indian infants and resolve with treatment.